Recoding of the Vesicular Stomatitis Virus L Gene by Computer-Aided Design Provides a Live, Attenuated Vaccine Candidate by Wang, Bingyin et al.
Recoding of the Vesicular Stomatitis
Virus L Gene by Computer-
Aided Design Provides a Live,
Attenuated Vaccine Candidate
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Wang, Bingyin, Chen Yang, Gergely Tekes, Steffen Mueller, Aniko
Paul, Sean P. J. Whelan, and Eckard Wimmer. 2015. “Recoding
of the Vesicular Stomatitis Virus L Gene by Computer-Aided





Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
Recoding of the Vesicular Stomatitis Virus L Gene by Computer-
Aided Design Provides a Live, Attenuated Vaccine Candidate
Bingyin Wang,a Chen Yang,a Gergely Tekes,d Steffen Mueller,a,c Aniko Paul,a Sean P. J. Whelan,b Eckard Wimmera,c
Department of Molecular Genetics and Microbiology, Stony Brook University School of Medicine, Stony Brook, New York, USAa; Department of Microbiology and
Immunobiology, Harvard Medical School, Boston, Massachusetts, USAb; Codagenix Inc., Stony Brook, New York, USAc; Faculty of Veterinary Medicine, Institute of Virology,
Justus-Liebig-University Giessen, Giessen, Germanyd
ABSTRACT Codon pair bias (CPB), which has been observed in all organisms, is a neglected genomic phenomenon that affects
gene expression. CPB results from synonymous codons that are paired more or less frequently in ORFeomes regardless of codon
bias. The effect of an individual codon pair change is usually small, but when it is amplified by large-scale genome recoding,
strikingly altered biological phenotypes are observed. The utility of codon pair bias in the development of live attenuated vac-
cines was recently demonstrated by recodings of poliovirus (a positive-strand RNA virus) and influenza virus (a negative-strand
segmented RNA virus). Here, the L gene of vesicular stomatitis virus (VSV), a nonsegmented negative-sense RNA virus, was par-
tially recoded based on codon pair bias. Totals of 858 and 623 silent mutations were introduced into a 5=-terminal segment of the
viral L gene (designated L1) to create sequences containing either overrepresented or underrepresented codon pairs, designated
L1sdmax and L1min, respectively. Analysis revealed that recombinant VSV containing the L1min sequence could not be recovered,
whereas the virus with the sdmax sequence showed amodest level of attenuation in cell culture. More strikingly, in mice the
L1sdmax virus was almost as immunogenic as the parental strain but highly attenuated. Taken together, these results open a new
road to attain a balance between VSV virulence and immunogenicity, which could serve as an example for the attenuation of
other negative-strand, nonsegmented RNA viruses.
IMPORTANCE Vesicular stomatitis virus (VSV) is the prototypic rhabdovirus in the orderMononegavirales. A wide range of hu-
man pathogens belong to this family. Using a unique computer algorithm and large-scale genome synthesis, we attempted to
develop a live attenuated vaccine strain for VSV, which could be used as an antigen delivery platform for humans. Recombinant
VSVs with distinct codon pair biases were rationally designed, constructed, and analyzed in both cell culture and an animal
model. One such recombinant virus, L1sdmax, contained extra overrepresented codon pairs in its L gene open reading frame
(ORF) and showed promise as an effective vaccine candidate because of a favorable balance between virulence and immunoge-
nicity. Our study not only contributes to the understanding of the underlying mechanism of codon pair bias but also may facili-
tate the development of live attenuated vaccines for other viruses in the orderMononegavirales.
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Nonsegmented, negative-sense (NNS) RNA viruses include awide range of established and emerging mammalian patho-
gens. Formost of them, neither vaccines nor antiviral therapeutics
with proven efficacy are available (1–3). Vesicular stomatitis virus,
an NNS virus of the Rhabdoviridae, is an arthropod-borne patho-
gen that primarily causes acute vesicular disease in livestock (4).
However, rare cases of human infection have been reported. Indi-
viduals infected with VSV usually develop mild flu-like symp-
toms, but a single case of encephalitis in a 3-year-old child has
been related to VSV infection (5). Nevertheless, VSV serves as an
attractive model to study a large number of mammalian patho-
gens of the Rhabdoviridae, including rabies virus (6).
Except for the members of the Orthomyxoviridae (e.g., influ-
enza viruses), whose RNA polymerase is a tripartite complex (7),
all the negative-strandRNAviruses encode a single large polymer-
ase protein, L, which contains all the enzymatic activities involved
in nucleotide polymerization (8) andmRNAmodification (9–11).
Amino acid sequence comparison of L proteins from multiple
NNS viruses revealed six conserved regions (CR I toVI), which led
to the notion that the large single L protein might be organized
into a series of domains that retain independent catalytic activities
(12).
VSV has been used extensively during the last four decades as a
laboratory tool to study molecular virology and cell biology. Its
relatively innocuous phenotype in human infection makes this
virus attractive for clinical application, a potential realized only
recently. However, VSV is an infectious agent with neurotoxicity
in experimental animals, which poses serious safety concerns for
direct human use (13, 14). Here, we report attempts to develop a
live attenuated VSV strain, making use of a genetic phenomenon
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known as codon pair bias (CPB) (15, 16). CPB, which has been
observed in ORFeomes of all organisms studied so far, describes
an unexpected irregularity of synonymous codon pairing in ge-
nomes of a specific phylum, independent of its genome-wide
codon usage. We previously reported that codon pairs are either
overrepresented or underrepresented in the genome of a particu-
lar organism (17). The nature of a codon pair can be defined by
calculating its codon pair bias score (CPS), which is the natural
logarithm of the ratio of the observed frequency of the codon pair
to the expected frequency. The average of the sumof all CPSs in an
ORF indicates the codon pair bias of the entire gene. In our pre-
vious experiments involving recoding of viral genomes, we have
shown that the viral gene expression can be intentionally altered
by a rational design of a coding sequence, based on codon pair bias
(17–20). More importantly, the alteration of gene expression is
likely a result of the numerous synonymous substitutions, which
makes phenotypic reversion nearly impossible (21). This specific
property of virus attenuation caused by changing codon pair bias
is critical for the development of vaccine strains against RNA vi-
ruses, like VSV, described here, whose spontaneous mutation
rates are much higher than those of DNA viruses and of other
microorganisms (22).
In this study, we examined the impact of recoding the VSV L
gene on virus replication in cell culture and on pathogenicity in
mice. By using computer-aided design and chemical cDNA syn-
thesis as described before (17, 19, 20), we constructed two recom-
binant versions of VSV, containing an excess of either underrep-
resented (“min”) or overrepresented (“sdmax”) codon pairs.
Because of the large size of the L ORF, we focused on the
N-terminal segment of the L gene, designating the recoded seg-
ments L1min and L1sdmax. The L1min design led to a nonviable
virus, probably because of poor expression of the L gene. Surpris-
ingly, the L1sdmax design causedmodest attenuation in cell culture,
whereas this variant was highly attenuated in the mouse model.
Moreover, the L1sdmax virus exhibited potent immunogenicity
that fully protected vaccinated mice from lethal challenge with
wild-type (WT) VSV. These observations suggest that the L1sdmax
virus could be developed into a promising vaccine candidate or a
vector for the delivery of immunologically important antigens.
RESULTS
Construction and characterizationof L recodedVSVvariants in
tissue culture. We recoded a large N-terminal segment of the L
gene ORF, L1, by computer algorithm-aided design (Fig. 1A).
Without alteration of codon usage or amino acid sequence, we
rearranged the positions of existing codons to generate either un-
FIG 1 Genome organization of VSV and construction of L variants. (A) The VSV genome consists of 2 untranslated regions (3= leader and 5= trailer; red boxes)
and 5 viral genes (N, P, M, G, and L). Like the other four viral genes, the VSV L ORF is flanked by the untranslated regulatory sequences (white boxes) that are
essential for transcription initiation and termination. The L1 region (blue box) is between nt 4961 and nt 7534, corresponding to amino acids 76 to 934 of the L
protein. L1sdmax and L1min sequences were synthesized de novo and incorporated into the parental plasmid pVSV1() to replace the WT sequence, using HpaI
and AvaI sites. (B) Codon pair bias of human genes and the L1 derivatives plotted against their amino acid lengths.
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derrepresented or overrepresented codon pairs, resulting in hun-
dreds of synonymous nucleotide substitutions (see Table S1 in the
supplemental material). Compared to its WT counterpart, L1min
has a much lower codon pair score, whereas L1sdmax has a signifi-
cantly higher one (Fig. 1B). We took into account a possible in-
crease in the frequency of XXCpGXX, a dinucleotide formed be-
tween two codons that may play a role in inducing an innate
immune response (23), and of XXUpAXX, a dinucleotide that at
high frequency has been proposed to reduce mRNA stability (24).
We particularly avoided generating extra AAAUU (AU-rich) se-
quences, which are signals for mRNA degradation (25). The dis-
tribution of overrepresented and underrepresented codon pairs in
these designs is graphed in Fig. S1 in the supplemental material.
A recombinant VSV bearing a “deoptimized” L gene (L1min) is
expected to be highly attenuated and possibly nonviable. On the
other hand, based on our previous experience in “maximizing”
the poliovirus P1 region, we anticipated that sdmax might not
affect L gene expression negatively (17). We initially included the
sdmax design in our study in order to rule out the possibility that
certain unidentified RNA sequences critical for virus replication
were accidentally modified during the large-scale recoding (26).
As shown in Table S1, about 33% of the nucleotides of the L1
region have been mutated in the L1sdmax design; therefore, theo-
retically, any important RNA signal or highly structured element
longer than 3 or 4 nucleotides (nt) would have been inactivated.
cDNAs corresponding to these recoded regions were chemi-
cally synthesized de novo and cloned into the parental antigenomic
plasmid pVSV1() to replace the WT sequence. The reverse ge-
netics of these recombinant viruses was carried out using the vac-
cinia virus-mediated system (27). The L1sdmax design yielded in-
fectious virus after one blind passage, whereas L1min failed to
generate a viable virus.
The growth phenotypes of the recombinant L1sdmax virus was
then analyzed in tissue culture. Compared to the WT virus, the
plaque phenotypes revealed slightly smaller sizes in BHK-21 cells
and A549 cells (Fig. 2A and B). Multistep growth kinetics, ana-
lyzed in BHK-21 or A549 cells by inoculation at a lowmultiplicity
of infection (MOI) of 0.1 or 0.001, showed maximal titers of
L1sdmax between 24 and 48 hpi that were comparable to that of the
WT virus. Viral replication of L1sdmax, however, was slightly de-
layed, independent of the cell type it infected. A quantitative re-
verse transcription-PCR (RT-PCR) assay that measured the level
of viral full-length RNA in infected BHK-21 cells supported the
delay of genome synthesis (Fig. 2C). To measure the yield of viral
proteins and expand the range of cell types, we then determined
the synthesis of N protein by immunocytochemistry inHeLa cells.
FIG 2 Multistep growth kinetics and plaque phenotypes ofWT and L1sdmax virus in BHK-21 cells (A) and A549 cells (B) at lowMOIs. (C)Quantitative RT-PCR
was conducted to quantitate the full-length viral RNA in WT- and L1sdmax-infected BHK-21 cells (MOI 3).
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In L1sdmax-infected cells, at 4 hpi, much less viral N protein was
detected than inWT virus-infected cells (see Fig. S2 in the supple-
mental material).
Reduced expression of the L protein encoded by the L1sdmax
sequence. During the early stages of virus infection, the slower
growth of the L1sdmax virus led to a reduced yield of all the viral
products (see Fig. S3 in the supplemental material). We were un-
able to explain the decreased level of L protein synthesis by simply
comparing the yields of viral protein to those of mRNA. To cir-
cumvent this problem, we constructed two L expression plasmids
(designated pLL1sdmax and pLL1min) (see Fig. S4 in the supplemen-
tal material) by replacing the cognate WT L open reading frames
of pLwith the synthetic L derivatives (L1sdmax and L1min).We then
examined the production of full-length L protein after transiently
transfecting BHK-21 cells that were previously infected with
vTF7-3. In this experimental setting, the entire L gene coding se-
quences are transcribed in the cytoplasm by T7 polymerase.
To increase the stability of the large polymerase polypeptide,
we cotransfected into BHK-21 cells a plasmid expressing the VSV
P protein together with the plasmid harboring the modified L
sequence (28). In comparison to translation of pLWT, translation
of the L1sdmax gene produced only a weak signal (Fig. 3A), even
though equal amounts of L transcripts were detected in pLWT- and
pLL1sdmax-transfected cells (Fig. 3B). This result was unexpected
given that codon pairing in L1sdmax has been designed to yield
mRNA favorable for translation (17). The synthesis of L1min was
even more inefficient than that of L1sdmax (see Fig. S4B in the
supplemental material). This was not totally unexpected, al-
though we do not know as yet whether the poor L1min synthesis is
due to an inhibition of translation per se or a rapid degradation of
mRNA prior to or during translation.
Another interesting observation is that the L1sdmax virus
showed an exquisite sensitivity to the pharmaceutical deprivation
of Hsp90 (see Fig. S5 in the supplemental material), a host chap-
erone molecule that has been identified to be essential for the
proper folding of the newly synthesized VSV L protein (29). It
raises the possibility that an enhanced chaperone engagementmay
be required for the L1sdmax virus.
Diminished virulence of the L1sdmax virus after intranasal in-
oculation of mice. As mentioned above, the poliovirus variant
P1max in which the capsid coding region was codon pair opti-
mized, was as lethal in CD155 transgenic mice as WT poliovirus
(17). We therefore tested the pathogenesis of L1sdmax virus in a
mouse model. Five- to six-week-old male BALB/c mice were in-
fected with different doses of WT or L1sdmax viruses intranasally.
WT-infectedmice lost weight rapidly and exhibited typical symp-
toms of infection starting around 3 dpi. Under our experimental
conditions, the 50% lethal dose (LD50) for WT VSV was 105 PFU
for intranasal infection. In contrast, neither mortality nor severe
morbidity was observed in any mice infected with the L1sdmax
virus, even at a very high infection titer (2 108 PFU) (see Fig. S6B
in the supplementalmaterial). Taking these data together, we con-
clude that L1sdmax virus is highly attenuated in BALB/c mice. This
was a surprise, but it matched our unpublished results obtained
with recoded dengue virus variants that phenotypes observed in
tissue culture with a codon pair-recoded virus do not necessarily
predict phenotypes of the same recoded virus when it is tested in
experimental animals.
Virus burdens in the infected organs. The efficacy of live at-
tenuated vaccines depends on reduced viral replication in vivo but
a successful stimulation of immunological memory (18). More-
over, virulence and virus load in infected organs are usually posi-
tively correlated (19). Therefore, we examined virus burden in the
infected animals by both plaque-forming assays and quantitative
RT-PCR. At 3 dpi, the virus load in the L1sdmax-infected organs
was at least two orders of magnitude less than that in their WT-
infected counterparts. On day 6, the infectious L1sdmax virus could
not be recovered in any of the mice lungs that we examined and
could be detected in only one brain sample (n  3) (Fig. 4A). In
contrast, inWT-virus-infected animals, a virus burden of approx-
imate 104 PFU/g was observed in brain tissues up to 6 dpi, which
ultimately resulted in the death of all the remaining animals by 9
dpi (data not shown). We also examined the viral RNA load in
mouse brains using quantitative RT-PCR (Fig. 4B). Total RNA
was extracted from infected brains, and a 150-bp fragment corre-
sponding to the viral N genewas amplified. Viral RNAwas present
in every brain of the infected animals, but the viral RNA load of
L1sdmax-infected animalswas lower than that ofWTvirus-infected
ones.
Disparate histopathology of WT- and L1sdmax-infected
brains. Even the limited replication of L1sdmax in the brains of
infected animals raises the question of whether such viral variants
could serve as vaccine candidates. We therefore carried out histo-
logical studies. BALB/c mice were infected intranasally with
107 PFU of viruses, and brains were harvested for hematoxylin-
and-eosin (H&E) staining after 5 days. Brain tissues infected with
FIG 3 The expression of L1sdmax sequence was examined by transfecting pLL1sdmax plasmid into BHK-21 cells that were previously infected with T7 polymerase
(Pol)-expressing vaccinia virus vTF7-3. (A) The L protein expression in transfected cells was examined by Western blotting. (B) The synthesis of L mRNA was
examined by quantitative RT-PCR (qRT-PCR). pt, posttransfection.
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WT VSV exhibited severe immunopathological characteristics,
evidenced by multifocal perivascular cuffing, mononuclear cell
infiltration in the parenchyma, meningeal mononuclear cell infil-
tration, and hemorrhage (Fig. 5), consistent with previous studies
(14, 30). Tissues collected from the L1sdmax group exhibit only
mild, if any, inflammatory changes upon virus infection.
VSV infection compromises the integrity of the blood-brain
barrier (BBB) (31). The destruction of BBB accompanied by the
intensive immunological infiltration causes severe immuno-
pathogenesis that leads directly to the death of experimental ani-
mals. Therefore, we used the well-established Evans blue assay to
assess the integrity of the BBB after virus infection, a method pro-
viding an additional indicator of virus pathogenesis (32). As
shown in Fig. S6C in the supplemental material, at 6 dpi the brain
of the animal infected with L1sdmax showed no sign of BBB dam-
age, whereas a widespread, intensive parenchyma staining was ap-
parent in the WT-infected brain, which is a clear sign of dimin-
ished BBB integrity.
The immune response in L1sdmax-infected mice.We next de-
termined whether the restricted replication of this viral variant
provides effective immunological protection against challenge
withWT virus.We vaccinated 5- to 6-week-old BALB/cmice with
different doses of L1sdmax virus intranasally. After 3 weeks, all mice
received 107 PFU of WT virus intranasally, representing an ap-
proximately 100-fold LD50 of WT VSV. None of the L1sdmax-
immunizedmice exhibited signs of disease, and their bodyweights
increased steadily, whereas age-matched naivemice succumbed to
challenge after 6 to 8 days (Fig. 6A).
We then asked whether the L1sdmax immunization elicited a B
cell-mediated humoral immunity. Sera were collected 21 days
postvaccination from tail vein blood, and titers of virus-specific
neutralizing antibodies (NAb) were measured. The L1sdmax virus
was capable of inducing a robust protective antibody response
(Fig. 6B). A similar level of NAb was detected in mice that were
immunized with the same amount of WT or L1sdmax virus,
whereas the control group did not develop a detectable humoral
response against VSV infection. Taken together, these data indi-
cate that a single-dose vaccination of the L1sdmax virus can elicit a
potent immune response that fully protects mice from a subse-
quent virulent challenge.
Prolonged induction of proinflammatory cytokines and
chemokines in WT- but not in L1sdmax-infected brains. During
VSV infection, mouse susceptibility correlated positively with ex-
tensive cytokine/chemokine expression in the central nervous sys-
tem (CNS) (14). To determine the nature of the inflammatory
response during L1sdmax infection, we profiled the transcription
levels of several proinflammatory cytokines and chemokines in
virus-infected brains. Compared to their WT-infected counter-
parts, MCP-1 and RANTES were induced to a lesser extent in
L1sdmax-infected mice (Fig. 7A). Additionally, at 3 dpi, L1sdmax-
infected mice showed levels of tumor necrosis factor alpha
(TNF-) and interleukin 6 (IL-6) similar to those of WT-infected
animals (Fig. 7B). WT-infected mice retained a high level of cyto-
kine production until 6 dpi, while L1sdmax-infectedmice showed a
significant decline of cytokine synthesis by then. This suggests that
in contrast to the highly attenuated L1sdmax virus, WT virus infec-
tion in the CNS cannot be controlled without a sustained inflam-
mation, which eventually leads to immunopathogenesis and irre-
versible neuron damage.
DISCUSSION
Impact of codonpair deoptimization on gene expression. In this
study, we evaluated the consequences of large-scale L gene recod-
ing upon VSV replication and pathogenesis. The L1 region com-
prises the coding sequences of domains I to III and part of domain
IV, which primarily forms the core ring structure of the VSV
RNA-dependent RNA polymerase (RdRp) and catalyzes RNA po-
lymerization (33). The L1min sequence yielded only trace amounts
of full-length L protein after transient expression in tissue culture
cells, which is reminiscent of data obtained with variants of codon
pair-deoptimized poliovirus and influenza virus (17–19).
Codon pair deoptimization appears to affect several mecha-
FIG 4 Attenuation of L1sdmax VSV in mice. (A) BALB/c mice were infected with WT or L1sdmax, and viral loads in organs were determined by plaque assay. At
6 dpi, the infectious viruses were undetectable in all but oneWT-infected lung, and the presence of infectious virus could be detected in only one L1sdmax-infected
brain (n  3). The dashed line indicates the limit of detection (30 PFU/g) for plaque assay. (B) The viral RNA loads in mice brains were measured using
quantitative RT-PCR (**, P 0.01 [two-tailed Mann-Whitney U test]).
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nisms that interfere with gene expression in a context-dependent
manner. For example, itmight be difficult for the ribosome to read
through a string of “rare” codon pairs, a predicament leading to
less protein production per mRNA. In addition, it is known that
the dinucleotide frequency of CpG and UpA in eukaryotic RNA
viruses, as well as in mammalian mRNA in general, is lower than
expected (34–36), a phenomenon that must be advantageous for
viruses. Generating rare codon pairs by rearranging existing syn-
onymous codons inadvertently leads to an enrichment of UpA
and CpG dinucleotides in the mRNA sequences. For instance, the
L1min but not the L1sdmax design contains significantly more
XXUpAXX and XXCpGXX dinucleotides than the WT sequence
(see Table S1 in the supplemental material), with the increase
mapping to between codons, as shown, since codon use remained
unchanged. Recent studies suggest that the dinucleotide compo-
sition in RNA virus genomes influences RNA virus replication,
possibly because of an unclear host-pathogen interaction (37)
and/or increased instability of the mRNA (23). Although we can-
not exclude the possibility that strengthened host recognition of
UpA/CpG dinucleotides contributed to the attenuation pheno-
type of our codonpair-deoptimized viruses, the reverse genetics of
L1min was conducted in BHK-21 cells, a cell line well known for its
deficiency in innate immune response (38). Hence, the nonviable
phenotype of the L1min design cannot be simply attributed to an
enhanced host response.
Impact of codon pair “scramble-max” on protein synthesis.
The most striking phenotype that we observed with L1sdmax is its
attenuation that results from an enrichment of overrepresented
codon pairs. Our previous experiments in which we “maximized”
the encoding of the poliovirus P1 region suggested that such ge-
netic alteration enhanced the expression of the corresponding vi-
ral ORF without affecting virulence (17). This appears to be con-
trary to the observation in this study. The attenuation of L1sdmax is
not host range restricted, because the virus forms smaller plaques
in all cell lines tested. Considering that the transcriptional regula-
tory sequences in the untranslated region of the L gene were never
altered, it becomes less likely that the L1sdmax sequence is inade-
quately transcribed by the viral polymerase. Indeed, the poor ex-
pression of the L1sdmax sequence does not seem to occur at the
transcription level, because (i) a high level of L mRNA was de-
FIG 5 Histopathology after VSV infection. Mice were inoculated with PBS (A and B), 107 PFUWT (C and D), or L1sdmax (E and F) virus intranasally, and the
horizontal brain sections containing cerebral cortex were stained with H&E at 5 dpi. Representative brain histology is shown for each group (magnification,
40). In panel C, solid yellow arrows indicate the perivascular cuffing, and dashed yellow arrows indicate the mononuclear cell infiltration in the brain
parenchyma. In panel D, solid black arrows indicate meningeal hemorrhage, and dashed black arrows indicate the meningeal mononuclear cell infiltration.
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tected when the L1sdmax sequence was placed under the control of
the T7 promoter and transfected into cells expressing T7 polymer-
ase (Fig. 3B) and (ii) during L1sdmax virus infection, the same
kinetics ofmRNA accumulation were found for the L andN genes
(see Fig. S3 in the supplemental material) (ranging from 1 hpi to
6 hpi).
Considering the possibility that an enhanced chaperone en-
gagementmight be required for the L1sdmax virus (see Fig. S5 in the
supplemental material), we hypothesized that the alteration of the
translation elongation rate, presumably caused by the accumula-
tion of overrepresented codon pairs, might interfere with the co-
ordination between translation and other events closely related to
translation rate, such as protein folding. Recent reports have
shown that clustered rare codons are frequently distributed be-
tween defined protein domains, especially for large multidomain
proteins. This distribution pattern of “slow” codonsmight collec-
tively reduce the read-through activity of the ribosome, which
turns out to be beneficial for proper protein folding (39, 40). An
early study conducted in a bacterial system also suggests that
codon pair utilization influences protein folding by altering trans-
lational efficiency, although only a small number of codon pairs
was included and analyzed at that time (41). Herein we speculate
that the folding efficiency of a multidomain protein, like the VSV
L protein described in this paper, might be perturbed by the large-
scale genome recoding. The relatively low codon pair bias in the
WT L1 region (Fig. 1B) might be a compromise between transla-
tion accuracy and folding efficiency.
L1sdmax serves as a candidate forVSV-basedvaccines andvec-
tors. VSV has been studied as an agent with unique oncolytic
properties aided by its broad tissue tropism and exquisite sensitiv-
ity to innate immunity, which result in its preferential replication
in tumors. In addition, VSV might serve as an excellent vaccine
delivery platform, because of its easily manipulated genome and
the capacity to stimulate a robust cytokine response via mucosal
delivery. In this study, we generated and identified a recombinant
virus, L1sdmax, which is highly attenuated (its LD50 is at least 2,000-
fold more than that of the WT). Our results showed that L1sdmax
underwent a limited replication and dissemination in vivo that
barely caused any morbidity, but this self-restricted infection was
highly immunogenic. The L1sdmax virus appears to be an attractive
live vaccine candidate applicable to other viruses in the order of
Mononegavirales that encode very large polymerase polypeptides.
In the development of vaccines, conventional strategies usually
lead to a limited number of mutations in viral genomes, whereas
L1sdmax carries in its L-encoding segment 858 point mutations.
We have passaged the L1sdmax virus 5 times in BHK-21 cells at low
MOIs, and we did not observe any phenotypic reversion (data not
shown), but long-term passaging is required to confirm genetic
stability. Of course, the current construct may have to be further
attenuated to avoid all proliferation in the CNS.
The recent Ebola outbreak in West Africa and the sporadic
cases in the Western Hemisphere have elicited international con-
cern. One of the most promising vaccine candidates against Ebola
infection, VSV-ZEBOV, is a VSV chimera that expresses Ebola
genetic information (42). It will be of interest to further evaluate
the safety and efficacy of L1sdmax as a platform to deliver foreign
antigens.
In summary, the present study describes the first large-scale
recoding of VSV, a rhabdovirus that belongs to a large family of
human pathogens. The outcome of the experiments is surprising
but nevertheless may herald a unique approach to develop live
attenuated strains for VSV and possibly other NNS viruses.
MATERIALS AND METHODS
Cells and viruses. BHK-21, Vero, A549, and HeLa cells were maintained
in Dulbecco’s modified Eagle medium (DMEM) plus 10% fetal bovine
serum at 37°C. WT VSV is recovered from the cDNA clone pVSV1(),
using the well-established vaccinia virus-mediated system (27). Briefly, to
FIG 6 Immunogenicity of the L1sdmax virus. (A) Dynamics of L1sdmax-immunized mice body weights after a lethal WT challenge at day 21. (B) Titers of
virus-specific neutralizing antibody (NAb) in WT- and L1sdmax-immunized mice 21 days after the primary exposure. For this experiment, n was 5 per group. A
larger number of animals (n 10) for the groups infected with 105 PFU of theWTwere initially immunized, because the infection titer is close to the LD50 ofWT
virus. The sera from the survivors (4/10) were subsequently collected at 21 dpi, and the titers of virus-specific neutralizing antibodywere determined as described
in Materials and Methods.
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construct the cDNA clone of L1sdmax or L1min virus, the HpaI-to-AvaI
fragment of pVSV1() was replaced with the corresponding synthetic
fragment L1sdmax or L1min (GenScript, NJ, USA) in which overrepre-
sented or underrepresented codon pairs were substantially enriched. The
recovered viruses were plaque purified, and their full-length sequences
were confirmed by RT-PCR.
Virus load and protection assay. Animal studies were carried out in
accordance with a protocol that adhered to theGuide for the Care and Use
of Laboratory Animals of the NIH (43) and was reviewed and approved
(approval number 354543) by the Stony Brook University Institutional
Animal Care and Use Committee (IACUC). Five- to six-week-old male
BALB/c mice (Taconic Farms, Inc.) were intranasally infected with 5 
106 PFU viruses, and at 3 and 6 dpi, their lungs and brains were harvested
for determinations of virus titers by plaque-forming assay. For viral RNA
load analysis, total RNA was extracted from brains of mice (TRIzol; Life
Technologies) that were infected with 5 106 PFU viruses, and the abun-
dance of viral RNA was subsequently evaluated by real-time RT-PCR
using a primer pair that recognizes the viral N gene (VSV N primer) (see
Table S2 in the supplemental material). In parallel, qPCR directed against
mouse-actinmRNAwas performed to control for any differences in the
amount of total RNA inputs (mouse -actin primer) (Table S2 in the
supplemental material). For protection assay, mice were vaccinated intra-
nasally with various doses of L1sdmax virus and challengedwith 107 PFUof
WTvirus at 21 days after vaccination. A group of age-matched virus-naive
mice (n  3) were challenged as well, as a negative control. After the
virulent challenge, the mice body weights and neuronal disorder symp-
toms were closely monitored for another 14 days.
Neutralizing antibody assay.Themice were immunized with various
doses of either WT or L1sdmax virus intranasally. The serum was isolated
from tail vein blood 21 days after vaccination, followed by a 2-fold serial
dilution in DMEM starting at a dilution of 1:20. Fifty microliters of the
diluted serum was incubated with 100 PFU WT VSV in 50 l DMEM at
37°C for 1 h. One hundred microliters of Vero cell suspension was then
combined with themixture and seeded on 96-well plates in triplicate. Cell
morphology was checked daily, and after a 48-h incubation at 37°C, the
remaining cells were stained with 1% crystal violet. The reciprocal of the
FIG 7 Cytokine/chemokine profile after virus infection. (A) Quantitative RT-PCR to measure chemokine (MCP-1 and RANTES) expression relative to the
mouse -actin after virus infection. (B) Proinflammatory cytokine induction in PBS-, WT-, and L1sdmax-inoculated mice. Data were collected from 4 to 6 mice
per group. Statistical significance is indicated by asterisks (*, P 0.05; **, P 0.01 [two-tailed Mann-Whitney U test]).
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dilution that gives 100% protection from VSV CPE was recorded as the
virus-specific neutralizing-antibody titer.
Histopathology.Mice were infected with 107 PFU virus by intranasal
inoculation and euthanized at 5 dpi. Mice were transcardially perfused
with 10% paraformaldehyde (PFA)-phosphate-buffered saline (PBS) and
their brains were harvested and fixed in 10% PFA-PBS, followed by 50%
ethanol processing and paraffin embedding. The brain tissues were sub-
sequently sectioned at 5mand stained withH&E. The histopathological
results were examined independently by two neuropathologists at the
School of Medicine, Stony Brook University.
Quantitative RT-PCR to analyze cytokine/chemokine inductions.
Total RNA was extracted from mice brains inoculated with PBS, WT, or
L1sdmax at both 3 and 6 dpi and then treatedwith RNase-freeDNase I (Life
Technologies) for 30 min at 37°C before a reverse transcription was con-
ducted with oligo(dT)20 (SuperScript III; Life Technologies). Quantita-
tive PCR was subsequently performed to evaluate the induction of cyto-
kines and chemokines using gene-specific primers (see Table S2 in the
supplemental material). All reactions were subsequently normalized to
the RNA levels of mouse -actin and reported as increases in induction
over that in PBS-inoculated animals.
Quantitative RT-PCR tomeasure viral genome replication.BHK-21
cells were infected with viruses at aMOI of 3. At various time points, total
RNA was extracted and reverse transcribed by random hexamer priming.
Quantitative PCR was carried out with a primer pair spanning the region
between the VSV G and L genes (see Table S2 in the supplemental mate-
rial) to measure the viral genome replication. The reaction results were
normalized to themRNA levels of the BHK-21GAPDHgene and reported
as the increase (fold) over the value at 0 hpi.
Plasmid construction and transient protein expression. The corre-
sponding region of the WT L gene in the expression plasmid pL (27) was
replaced by two recoded derivatives using the XhoI and XbaI digestion
sites. For transient expression, 106 BHK-21 cells were infected with
vTF7-3 for 1 h and then cotransfected with 1.5 g pP and 1.25 g pL
derivatives. Whole-cell lysates and total RNA were harvested at various
time points, and the yield of viral products was subsequently determined
by Western blotting and quantitative RT-PCR.
Statistical analysis. Statistical analysis was performed using Graph-
Pad Prism software version 5.0c (San Diego, CA). Data are presented as
meanswith standard deviations (SDs). Two-tailedMann-WhitneyU tests
were used for Fig. 4B and 7.
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